We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+6.76%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$424M
AUM Growth
+$18.8M
Cap. Flow
-$6.82M
Cap. Flow %
-1.61%
Top 10 Hldgs %
15.99%
Holding
311
New
46
Increased
58
Reduced
107
Closed
45

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$1.03M
2
MCD icon
McDonald's
MCD
+$757K
3
CL icon
Colgate-Palmolive
CL
+$417K
4
GLW icon
Corning
GLW
+$349K
5
WPC icon
W.P. Carey
WPC
+$342K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$990K
2
TIF
Tiffany & Co.
TIF
+$591K
3
ADBE icon
Adobe
ADBE
+$473K
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$431K
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$429K

Sector Composition

Rank Sector Weight
1 Technology 18.53%
2 Industrials 16.81%
3 Healthcare 10.71%
4 Consumer Discretionary 7.02%
5 Financials 6.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MIME
76
DELISTED
Mimecast Limited
MIME
$1.49M 0.35%
34,445
-4,127
-11% -$172K
WTRG icon
77
Essential Utilities
WTRG
$11.2B
$1.49M 0.35%
31,655
-234
-0.7% -$10.5K
LDOS icon
78
Leidos
LDOS
$13.5B
$1.48M 0.35%
15,089
-832
-5% -$73.3K
ENTG icon
79
Entegris
ENTG
$20.4B
$1.47M 0.35%
29,430
+2,454
+9% +$118K
UNH icon
80
UnitedHealth
UNH
$383B
$1.47M 0.35%
4,989
-520
-9% -$136K
JCI icon
81
Johnson Controls International
JCI
$85B
$1.45M 0.34%
35,550
-1,789
-5% -$75.5K
EGRX
82
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1.44M 0.34%
24,000
– –
VTR icon
83
Ventas
VTR
$46.8B
$1.44M 0.34%
24,912
+4,316
+21% +$271K
HBAN icon
84
Huntington Bancshares
HBAN
$36.6B
$1.41M 0.33%
93,678
-4,616
-5% -$67.7K
LYB icon
85
LyondellBasell Industries
LYB
$19.6B
$1.41M 0.33%
14,869
-1,905
-11% -$175K
TTEK icon
86
Tetra Tech
TTEK
$8.12B
$1.39M 0.33%
80,860
+5,215
+7% +$90.3K
KNSL icon
87
Kinsale Capital Group
KNSL
$8.07B
$1.34M 0.32%
13,196
+1,258
+11% +$125K
MRK icon
88
Merck
MRK
$307B
$1.32M 0.31%
15,236
-677
-4% -$55.6K
CCMP
89
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$1.32M 0.31%
9,136
+997
+12% +$142K
NDAQ icon
90
Nasdaq
NDAQ
$52B
$1.31M 0.31%
36,729
+582
+2% +$19.8K
DIS icon
91
Walt Disney
DIS
$167B
$1.31M 0.31%
9,037
-690
-7% -$96.3K
MET icon
92
MetLife
MET
$59.8B
$1.3M 0.31%
25,456
-1,304
-5% -$62.9K
ABBV icon
93
AbbVie
ABBV
$448B
$1.27M 0.3%
14,325
-921
-6% -$76.5K
EXP icon
94
Eagle Materials
EXP
$6.23B
$1.25M 0.29%
13,761
+860
+7% +$78.8K
SLAB icon
95
Silicon Laboratories
SLAB
$7.17B
$1.22M 0.29%
10,502
+670
+7% +$73.5K
MDT icon
96
Medtronic
MDT
$107B
$1.19M 0.28%
10,507
-1,109
-10% -$122K
NTAP icon
97
NetApp
NTAP
$31.6B
$1.17M 0.28%
18,846
-3,564
-16% -$208K
NOC icon
98
Northrop Grumman
NOC
$74.4B
$1.17M 0.28%
3,405
-264
-7% -$92.8K
SJM icon
99
J.M. Smucker
SJM
$12B
$1.17M 0.28%
11,194
-1,152
-9% -$122K
EVRG icon
100
Evergy
EVRG
$19.6B
$1.16M 0.27%
17,841
-438
-2% -$27.9K
2 3
4
5 6

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
TFM
TFC Financial Management Boston, Massachusetts $812M AUM 17.34% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return

Stanley-Laman Group's Q4 2019 Portfolio in Review

As of Q4 2019, Stanley-Laman Group held 311 positions worth $424M, up 4.6% from $405M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Stanley-Laman Group's Q4 2019 filing shows 46 new, 58 increased, 107 reduced and 45 closed positions. Its largest new stake was McDonald's: 3,817 shares worth $754K. The largest sale was Celgene Corp, an estimated $990K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Industrials and Healthcare.

  • Stanley-Laman Group's largest Q4 2019 buy was McDonald's: 3,817 shares worth $754K.
  • Stanley-Laman Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.03M increase.
  • Stanley-Laman Group's biggest Q4 2019 reduction was Tiffany & Co., cutting an estimated $591K.
  • Stanley-Laman Group fully exited Celgene Corp in Q4 2019, selling an estimated $990K.
  • Stanley-Laman Group's ten largest holdings make up 16% of its $424M portfolio in Q4 2019.
  • Stanley-Laman Group opened 46 new positions and closed 45 in Q4 2019.
  • Stanley-Laman Group's portfolio value rose 4.6% quarter-over-quarter to $424M.

Based on Stanley-Laman Group's 13F filing for Q4 2019, filed 4 Feb 2020.